Allscripts announces second quarter 2018 results

Go back to Allscripts announces second quarter 2018 results

Allscripts (MDRX) PT Raised to $16 at Dougherty & Co

August 6, 2018 7:35 AM UTC

Dougherty & Co raised its price target on Allscripts (NASDAQ: MDRX) to $16.00 (from $15.50) while maintaining a Buy rating.

Analyst Gene Mannheimer said intent to sell NetSmart more than offsets weak bookings quarter.

... More

Allscripts (MDRX) Reports In-Line Q2 EPS, Offers Guidance, Approves $250M Buyback

August 2, 2018 4:03 PM UTC

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter came in at $536 million versus the consensus estimate of $538.16 million.

GUIDANCE:

Allscripts sees FY2018 EPS of $0.72-$0.82 vs $0.77. Allscripts sees FY2018 revenue of $2.15-2.25 million, versus the... More